Literature DB >> 7542307

IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1.

H E Chuluyan1, T J Schall, T Yoshimura, A C Issekutz.   

Abstract

We investigated the effect of interleukin-1 (IL-1) activation of human umbilical vein endothelium (HUVE) on human monocyte transendothelial migration induced by chemotactic factors. Monocyte migration across unactivated endothelium in response to macrophage inflammatory protein-1 alpha (MIP-1 alpha), RANTES, platelet-activating factor (PAF), or monocyte chemoattractant protein-1 (MCP-1) was completely inhibited (90%) by monoclonal antibodies (mAbs; 60.3) to CD18 of the CD11/CD18 complex on the monocyte and partially inhibited (by 75%) in response to C5a. When the HUVE was stimulated with IL-1 alpha (5 h, 0.1 ng/ml), monocyte migration in response to C5a, MIP-1 alpha, RANTES, or PAF was no longer inhibited by mAb to CD18. However, migration was blocked by the combination of mAb to the alpha 4-integrin (CD49d) chain of very late antigen-4 (CD49d/CD29) with the mAb to CD18. In contrast to the above stimuli, activation of the HUVE with IL-1 alpha inhibited the transendothelial migration of monocytes in response to MCP-1. mAbs to the adhesion molecules up-regulated on HUVE by IL-1, i.e., E-selectin (CD62E), intercellular adhesion molecule-1 (CD54) or vascular cell adhesion molecule-1 (CD106), did not reverse the inhibitory effect. Transendothelial migration in response to MCP-1 but not to C5a was inhibited by the treatment of monocytes with culture supernatant from IL-1 alpha-stimulated (but not from unstimulated) HUVE. Such supernatant contained chemotactic activity for monocytes, and a mAb to MCP-1 blocked the migration inhibitory effect of IL-1 activation of the HUVE monolayer, as well as the chemotactic activity in the supernatant from IL-1-stimulated HUVE. The inhibitory effect on migration of IL-1-stimulated HUVE was specific for monocytes because polymorphonuclear leukocyte transendothelial migration in response to IL-8 (a related chemokine) was not inhibited by IL-1 activation of HUVE.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542307     DOI: 10.1002/jlb.58.1.71

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.

Authors:  M Goebeler; B Schnarr; A Toksoy; M Kunz; E B Bröcker; A Duschl; R Gillitzer
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 2.  Alpha 4-integrin-dependent emigration of monocytes.

Authors:  H E Chuluyan; A C Issekutz
Journal:  Springer Semin Immunopathol       Date:  1995

3.  p85alpha subunit of class IA PI-3 kinase is crucial for macrophage growth and migration.

Authors:  Veerendra Munugalavadla; Jovencio Borneo; David A Ingram; Reuben Kapur
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

4.  Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.

Authors:  C Weber; R Alon; B Moser; T A Springer
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

5.  Glia Maturation Factor-γ Regulates Monocyte Migration through Modulation of β1-Integrin.

Authors:  Wulin Aerbajinai; Lunhua Liu; Jianqiong Zhu; Chutima Kumkhaek; Kyung Chin; Griffin P Rodgers
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

6.  IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.

Authors:  Shiva Shahrara; Sarah R Pickens; Arthur M Mandelin; William J Karpus; Qiquan Huang; Jay K Kolls; Richard M Pope
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

7.  Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.

Authors:  Salim S Virani; Vijay Nambi; Ron Hoogeveen; Bruce A Wasserman; Josef Coresh; Franklyn Gonzalez; Lloyd E Chambless; Thomas H Mosley; Eric Boerwinkle; Christie M Ballantyne
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

Review 8.  ATL and HTLV-I: in vivo cell growth of ATL cells.

Authors:  T Uchiyama
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

9.  Deficiency of KLF4 compromises the lung function in an acute mouse model of allergic asthma.

Authors:  Jeanette A Nimpong; Wintana Gebregziabher; Udai P Singh; Prakash Nagarkatti; Mitzi Nagarkatti; Johnie Hodge; Chunming Liu; Daping Fan; Walden Ai
Journal:  Biochem Biophys Res Commun       Date:  2017-09-01       Impact factor: 3.575

10.  Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.

Authors:  Hong Zhang; Andrew C Issekutz
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.